Leadership Overview
GSK has 10 executives leading key functions including finance, marketing, and digital operations.
Driven by a mission to unite science, technology, and talent, GSK aims to positively impact the health of 2.5 billion people by the end of the decade through its innovative medicines and vaccines.
Driven by a mission to unite science, technology, and talent, GSK aims to positively impact the health of 2.5 billion people by the end of the decade through its innovative medicines and vaccines.
Leadership Roles at GSK
Lillian Truesdell - Chief of Staff To Vice President Finance and Chief Financial Officer US
Lillian Truesdell, the Chief of Staff To Vice President Finance and Chief Financial Officer US at GSK, supports the financial operations within the United States. This role involves coordinating strategic initiatives and ensuring alignment between the Vice President of Finance and the Chief Financial Officer's objectives. Truesdell facilitates communication across departments, manages key projects, and drives operational efficiency within the finance division. The scope of this position includes overseeing budget management, financial reporting processes, and the implementation of new financial systems. By ensuring seamless execution of financial strategies, Lillian Truesdell contributes to the company's overall fiscal health and strategic growth in the US market. This leadership function is critical for maintaining robust financial governance and supporting GSK's research and development endeavors.
Hasham Baber - Chief Financial Officer & Director, Finance (Pakistan)
Hasham Baber, the Chief Financial Officer & Director, Finance (Pakistan) at GSK, leads all financial operations and strategic financial planning within Pakistan. Baber oversees fiscal management, ensuring compliance with local regulations and international financial standards. This executive position involves managing budgets, financial reporting, and investment strategies to support GSK's growth in the Pakistani market. The responsibilities include driving financial performance, optimizing resource allocation, and mitigating financial risks. By providing critical financial insights and direction, Hasham Baber plays a vital role in the company's regional success. Baber's financial acumen strengthens GSK's operational capabilities and contributes to its mission of improving health outcomes in Pakistan through accessible medicines and vaccines.
Gregory Naugle - Site Lead Finance Partner & Chief Financial Officer
Gregory Naugle, the Site Lead Finance Partner & Chief Financial Officer at GSK, directs financial strategy and operations for key GSK sites. Naugle ensures robust financial planning, analysis, and reporting, supporting site-specific operational excellence and strategic objectives. This leadership role involves close collaboration with site leadership to optimize resource allocation, manage budgets effectively, and drive financial performance. The scope includes overseeing financial controls, identifying cost-saving opportunities, and ensuring compliance with all financial regulations. By providing strategic financial guidance, Gregory Naugle enhances the operational efficiency and profitability of the sites under management. Naugle's expertise is crucial for maintaining GSK's financial integrity and supporting its global mission to deliver innovative healthcare solutions.
Redouane Tazi - Chief Financial Officer (Morocco, Tunisia)
Redouane Tazi, the Chief Financial Officer (Morocco, Tunisia) at GSK, directs financial strategy and management for operations in Morocco and Tunisia. Tazi ensures rigorous financial planning, accurate reporting, and effective budget control across both markets. This executive position involves optimizing financial performance, managing fiscal risks, and supporting strategic business decisions. The scope includes overseeing accounting practices, treasury functions, and compliance with local financial regulations. By providing expert financial leadership, Redouane Tazi strengthens GSK's financial foundation in North Africa. Tazi's contributions are essential for driving sustainable growth and ensuring the effective delivery of GSK's healthcare solutions to patients in Morocco and Tunisia.
Carolyn Grady - Chief Revenue Officer, Scinovo Management (CMC)
Carolyn Grady, the Chief Revenue Officer, Scinovo Management (CMC) at GSK, directs revenue generation strategies for the Scinovo Management division, focusing on Chemistry, Manufacturing, and Controls (CMC). Grady architects commercial plans to maximize revenue streams, overseeing sales operations and market penetration efforts. This executive role involves forging strategic partnerships and expanding market reach for GSK's pharmaceutical products. The responsibilities encompass driving sales performance, analyzing market trends, and identifying new revenue opportunities within the CMC sector. By optimizing the sales funnel and enhancing customer engagement, Carolyn Grady directly impacts the company's financial performance and market leadership. Grady's leadership ensures that GSK's manufacturing and control processes translate into significant commercial success, supporting the delivery of vital medicines globally.
Michael Escamilla - Digital, Data & Technology Chief of Staff (US)
Michael Escamilla, the Digital, Data & Technology Chief of Staff (US) at GSK, spearheads the strategic integration of digital, data, and technology initiatives across the United States operations. Escamilla drives the execution of the company's digital transformation agenda, ensuring technological advancements align with business objectives. This role involves coordinating cross-functional teams, managing technology roadmaps, and optimizing data utilization for enhanced decision-making. The scope includes overseeing the implementation of innovative digital solutions and data analytics platforms that support GSK's research, development, and commercial activities. By fostering a culture of technological innovation, Michael Escamilla enhances operational efficiency and accelerates the delivery of new medicines and vaccines. Escamilla's leadership ensures GSK remains at the forefront of digital and data-driven advancements in the pharmaceutical industry.
Soke Ng - Supply & Business Executive & Chief Marketing Officer (Asia Pacific)
Soke Ng, the Supply & Business Executive & Chief Marketing Officer (Asia Pacific) at GSK, drives integrated supply chain and marketing strategies across the Asia Pacific region. Ng orchestrates commercial initiatives to enhance market presence and revenue growth, while simultaneously optimizing supply chain operations for efficiency and reliability. This dual executive role involves aligning marketing efforts with supply capabilities to ensure timely delivery of GSK's medicines and vaccines. The responsibilities encompass developing market-specific strategies, managing distribution networks, and leading customer engagement programs. By bridging supply chain excellence with targeted marketing, Soke Ng significantly contributes to GSK's regional success and its mission to improve patient health. Ng's leadership ensures GSK effectively meets the healthcare needs of diverse populations across Asia Pacific.
Sheza Fatima - Chief Marketing Officer, Vaccine Customer Service & Logistics Lead Gulf
Sheza Fatima, the Chief Marketing Officer, Vaccine Customer Service & Logistics Lead Gulf at GSK, spearheads marketing strategies and oversees customer service and logistics for vaccines in the Gulf region. Fatima develops and executes comprehensive marketing plans to drive vaccine adoption and ensure exceptional customer experiences. This executive role involves managing the entire vaccine supply chain, from distribution to customer support, guaranteeing product availability and accessibility. The responsibilities include analyzing market dynamics, identifying customer needs, and implementing innovative service solutions. By ensuring efficient logistics and superior customer engagement, Sheza Fatima plays a critical role in expanding vaccine access and protecting public health in the Gulf. Fatima's leadership strengthens GSK's commitment to delivering life-saving vaccines.
Jesse Parker - Manager, Quality of Small Molecules & Chief Marketing Officer
Jesse Parker, the Manager, Quality of Small Molecules & Chief Marketing Officer at GSK, integrates quality management for small molecule products with overarching marketing strategies. Parker ensures that the high quality of GSK's small molecule pharmaceuticals is effectively communicated to target markets, driving commercial success. This executive role involves overseeing quality assurance processes while simultaneously developing and implementing marketing campaigns. The responsibilities include maintaining stringent quality standards and translating product benefits into compelling market messages. By aligning quality control with strategic marketing, Jesse Parker enhances product reputation and market penetration. Parker's leadership ensures that GSK's commitment to quality is a key driver of its commercial performance and patient trust.
Brett Derry - Lead, Medical Cx, Strategy & Performance, Medical Affairs Chief of Staff
Brett Derry, the Lead, Medical Cx, Strategy & Performance, Medical Affairs Chief of Staff at GSK, enhances the strategic execution and performance within the Medical Affairs division. Derry coordinates key initiatives, ensuring alignment between strategy, customer experience (Cx), and overall performance metrics. This role involves facilitating communication and operational flow between Medical Affairs leadership and cross-functional teams. The scope includes driving strategic planning processes, monitoring performance indicators, and optimizing the customer journey for healthcare professionals. By ensuring seamless operational execution and strategic focus, Brett Derry supports GSK's mission to advance scientific understanding and patient care. Derry's leadership strengthens the impact of Medical Affairs in delivering value to patients and healthcare providers.
Explore Leadership Teams in Manufacturing
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership IH
KN
AA
WS
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership

SC
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership MM
AA
AG
CL
Zai Lab functions as a bio-pharmaceutical and drug discovery company with a focus in oncology and autoimmune diseases. The company was established in 2014 and is headquartered out of Shanghai, China.
Company Leadership DL
HR

XW